Skip to Content
Incorporated in 1979, Boston Scientific develops and manufactures medical devices for customers in the U.S. and various international markets and emerging markets. The slowdown in elective surgeries in 2020, due to the pandemic, hurt Boston Scientific's business: Revenue sank 8% to $9.9 billion and the company lost $82 million. In the first quarter of 2021, however, the company reported sales growth in each of its reportable segments and an 8% year-over-year increase in net sales.
Courtesy of Boston Scientific
Lists ranking Boston Scientific
Fortune 500 - 2021This year’s Fortune 500 marks the 67th running of ...READ MOREview in list
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list
Latest news for Boston Scientific